The DOI matches its Crossref record; 297 of the 299 references it cites were found in a registry or an index.
Master Regulators of Muscle Atrophy: Role of Costamere Components
Open accessAbstract
The loss of muscle mass and force characterizes muscle atrophy in several different conditions, which share the expression of atrogenes and the activation of their transcriptional regulators. However, attempts to antagonize muscle atrophy development in different experimental contexts by targeting contributors to the atrogene pathway showed partial effects in most cases. Other master regulators might independently contribute to muscle atrophy, as suggested by our recent evidence about the co-requirement of the muscle-specific chaperone protein melusin to inhibit unloading muscle atrophy development. Furthermore, melusin and other muscle mass regulators, such as nNOS, belong to costameres, the macromolecular complexes that connect sarcolemma to myofibrils and to the extracellular matrix, in correspondence with specific sarcomeric sites. Costameres sense a mechanical load and transduce it both as lateral force and biochemical signals. Recent evidence further broadens this classic view, by revealing the crucial participation of costameres in a sarcolemmal “signaling hub” integrating mechanical and humoral stimuli, where mechanical signals are coupled with insulin and/or insulin-like growth factor stimulation to regulate muscle mass. Therefore, this review aims to enucleate available evidence concerning the early involvement of costamere components and additional putative master regulators in the development of major types of muscle atrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [113]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“The European Working Group on Sarcopenia in Older People defines sarcopenia by the presence of low appendicular lean mass/height2 and altered muscle strength, relative to sex-specific threshold values, and presarcopenia by the presence of decreased muscle mass without impact on muscle force development and contraction…”
BackgroundThe Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924 · cited 1×
“ATF4 protein synthesis increases in response to eIF-2-alpha phosphorylation consequent to PERK activation, and regulates gene expression of the transcription factor CHOP [56].”
BackgroundNitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797 · cited 3×
“The reduced S-nitrosylation of p53, secondary to a defective shuttle of nNOS to the nucleoskeleton, results in MuRF-1 gene upregulation [77], which is among the few atrogenes involved in sarcopenia [7,26].”
BackgroundAtrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774 · cited 1×
“The pioneering studies from Bodine’s and Goldberg’s laboratories [16,17] identified key genes, whose upregulation is shared in every of these conditions and leads to muscle atrophy development (the so-called atrogenes).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“Some reports suggest that chronic activation of p53 leads to premature myofiber aging associated with a significant atrophy [74,75].”
BackgroundIKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270 · cited 1×
“In line, the muscle wasting secondary to radiation therapy can be blocked by chemical inhibition of p53 [78].”
BackgroundAnabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., Taylor, P. M., & Rennie, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2640fje · Cited by 1,211
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,113 · cited 4×
“Although the involvement of p21 up-regulation in several muscle atrophy types still awaits investigations to explore possible additional functions [16], a lower number of muscle nuclei (both satellite cell and true myonuclei) and lower BrdU incorporation characterize rat soleus muscle after denervation, implying reduc…”
BackgroundInfluentialCellular Mechanotransduction: From Tension to Function
Martino, F., Perestrelo, A. R., Vinarský, V., Pagliari, S., & Forte, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00824 · Cited by 971
Mitochondrial dysfunction and oxidative stress in heart disease
Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T., & Kwong, J. Q. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0355-7 · Cited by 950 · cited 1×
“Mitochondria-targeted antioxidants, such as SS-31 and MitoTEMPO [99], were administered to laboratory rats before exposure to either a 12 h bout of mechanical ventilation [88] or a 6 h bout of hindlimb unloading [30].”
MethodReversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 940
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924 · cited 1×
“NF-κB activation in skeletal muscle has also been found directly responsible for inducing the expression of the ubiquitin ligase MuRF-1 [41] and for negatively regulating MyoD gene expression [39].”
BackgroundArber, S., Hunter, J. J., Ross, J., Hongo, M., Sansig, G., Borg, J., Perriard, J.-C., Chien, K. R., & Caroni, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81878-4 · Cited by 838
Sarcopenia: characteristics, mechanisms and functional significance
Narici, M. V., & Maffulli, N. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq008 · Cited by 827 · cited 1×
“The key difference between disuse atrophy and sarcopenia is the presence of a decrease in size and number of muscle fibers in the latter, whereas the former involves a decrease in fiber size only [10].”
BackgroundKnöll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01226-6 · Cited by 786
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Yoshida, T., & Delafontaine, P. (2020) · Cells · doi:10.3390/cells9091970 · Cited by 714
Milan, G., Romanello, V., Pescatore, F., Armani, A., Paik, J.-H., Frasson, L., Seydel, A., Zhao, J., Abraham, R., Goldberg, A. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7670 · Cited by 709 · cited 1×
“A comparable partial effect occurred for denervation-induced atrophy in mice with multiple FoxO KO [24].”
BackgroundILK, PINCH and parvin: the tIPP of integrin signalling
Legate, K. R., Montañez, E., Kudlacek, O., & Füssler, R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1789 · Cited by 676
Wilkinson, S. B., Phillips, S. M., Atherton, P. J., Patel, R., Yarasheski, K. E., Tarnopolsky, M. A., & Rennie, M. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.153916 · Cited by 628
Muscle type and fiber type specificity in muscle wasting
Ciciliot, S., Rossi, A. C., Dyar, K. A., Blaauw, B., & Schiaffino, S. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.016 · Cited by 623 · cited 2×
“Although muscle atrophy is characterized by the loss of muscle mass and force, it develops in each of the above listed conditions with specific signatures [1], whose features cannot be separated from a comprehensive mechanistic view.”
BackgroundSacheck, J. M., Ohtsuka, A., McLary, S. C., & Goldberg, A. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2004 · Cited by 606
Li, Y.-P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D. L., & Reid, M. B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2364com · Cited by 600
Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
Sacheck, J. M., Hyatt, J. K., Raffaello, A., Thomas Jagoe, R., Roy, R. R., Reggie Edgerton, V., Lecker, S. H., & Goldberg, A. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-6604com · Cited by 585
The Dystrophin Complex: Structure, Function, and Implications for Therapy
Gao, Q. Q., & McNally, E. M. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140048 · Cited by 456
Talts, J. F., Andac, Z., Göhring, W., Brancaccio, A., & Timpl, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.863 · Cited by 454
Costameres: the Achilles' Heel of Herculean Muscle
Ervasti, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200021200 · Cited by 446
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
Moresi, V., Williams, A. H., Meadows, E., Flynn, J. M., Potthoff, M. J., McAnally, J., Shelton, J. M., Backs, J., Klein, W. H., Richardson, J. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.004 · Cited by 444
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ
LANGEN, R. C. J., SCHOLS, A. M. W. J., KELDERS, M. C. J. M., WOUTERS, E. F. M., & JANSSEN-HEININGER, Y. M. W. (2001) · The FASEB Journal · doi:10.1096/fj.00-0463 · Cited by 415
Glover, E. I., Phillips, S. M., Oates, B. R., Tang, J. E., Tarnopolsky, M. A., Selby, A., Smith, K., & Rennie, M. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160333 · Cited by 414
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397 · cited 4×
“Activation of FoxO3 results from the deregulation of several signaling systems, among which are: (i) the derangement of the Insulin Receptor (IR) cascade [19], (ii) the untethering of the neuronal isoform of Nitric Oxide Synthase (nNOS) from sarcolemma [27–30], (iii) the excessive activation of the anabolic response […”
BackgroundInfluentialWhy Calcium? How Calcium Became the Best Communicator
Carafoli, E., & Krebs, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.735894 · Cited by 383
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Peixoto da Silva, S., Santos, J. M. O., Costa e Silva, M. P., Gil da Costa, R. M., & Medeiros, R. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12528 · Cited by 371 · cited 1×
“Asthenia has been recently recognized as a relevant clinical condition, which is influenced by patient’s subjectivity and difficult to diagnose [13].”
BackgroundFunctional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Saoncella, S., Echtermeyer, F., Denhez, F., Nowlen, J. K., Mosher, D. F., Robinson, S. D., Hynes, R. O., & Goetinck, P. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2805 · Cited by 368
Muller, F. L., Song, W., Jang, Y. C., Liu, Y., Sabia, M., Richardson, A., & Van Remmen, H. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00767.2006 · Cited by 355 · cited 3×
“increased ROS production and expression of mitochondrial anti-oxidant enzymes oxidative stress [103,104,244]”
BackgroundGene expression profile of aging in human muscle
Welle, S., Brooks, A. I., Delehanty, J. M., Needler, N., & Thornton, C. A. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00049.2003 · Cited by 353
Price, S. R., Bailey, J. L., Wang, X., Jurkovitz, C., England, B. K., Ding, X., Phillips, L. S., & Mitch, W. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118968 · Cited by 349
The role of myostatin in muscle wasting: an overview
Elkina, Y., von Haehling, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0035-5 · Cited by 348
Vandebrouck, C., Martin, D., Schoor, M. C.-V., Debaix, H., & Gailly, P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200203091 · Cited by 344
Shirasu, K., Lahaye, T., Tan, M.-W., Zhou, F., Azevedo, C., & Schulze-Lefert, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81522-6 · Cited by 343
De Boer, M. D., Selby, A., Atherton, P., Smith, K., Seynnes, O. R., Maganaris, C. N., Maffulli, N., Movin, T., Narici, M. V., & Rennie, M. J. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.142828 · Cited by 343
Integrins in mechanotransduction
Ross, T. D., Coon, B. G., Yun, S., Baeyens, N., Tanaka, K., Ouyang, M., & Schwartz, M. A. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.05.006 · Cited by 341
Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M., Pallafacchina, G., Paoli, A., et al. (2013) · Biogerontology · doi:10.1007/s10522-013-9432-9 · Cited by 340 · cited 5×
“Increased myostatin signaling has been hypothesized to play a major role in sarcopenia development [34], although no apparent increase in myostatin levels affects sarcopenic humans [25].”
BackgroundInfluentialMechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin
Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., & Cabello, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00074-0 · Cited by 337 · cited 1×
“Myostatin plays a role also in cancer cachexia, where it impairs muscle mass regulation via p53 and p21 upregulation [55].”
BackgroundMourkioti, F., Kratsios, P., Luedde, T., Song, Y.-H., Delafontaine, P., Adami, R., Parente, V., Bottinelli, R., Pasparakis, M., & Rosenthal, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28721 · Cited by 315 · cited 8×
“However, AICAR did not blunt MAFbx/Atrogin-1 and MuRF-1 upregulation [31], suggesting that other pathways than phosphorylated p70S6K are involved.”
BackgroundInfluentialAcharyya, S., Butchbach, M. E. R., Sahenk, Z., Wang, H., Saji, M., Carathers, M., Ringel, M. D., Skipworth, R. J. E., Fearon, K. C. H., Hollingsworth, M. A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.004 · Cited by 314
NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy
Thoma, A., & Lightfoot, A. P. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-1435-3_12 · Cited by 313 · cited 1×
“The activation of the NF-κB pathway in skeletal muscle atrophy is mainly due to the binding of cytokines on muscle surface receptors [42].”
BackgroundBirk, A. V., Chao, W. M., Bracken, C., Warren, J. D., & Szeto, H. H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12468 · Cited by 306 · cited 1×
“drial electron transport and ATP synthesis [100], but changes in cardiolipin amount and composition after short exposure to muscle inactivity have not been investigated yet.”
BackgroundDynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles
Schmalbruch, H., & Lewis, D. M. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200004)23:4<617::aid-mus22>3.0.co;2-y · Cited by 298 · cited 1×
“Although the involvement of p21 up-regulation in several muscle atrophy types still awaits investigations to explore possible additional functions [16], a lower number of muscle nuclei (both satellite cell and true myonuclei) and lower BrdU incorporation characterize rat soleus muscle after denervation, implying reduc…”
BackgroundActivation of an alternative NF‐ΚB pathway in skeletal muscle during disuse atrophy
Hunter, R. B., Stevenson, E. J., Koncarevic, A., Mitchell-Felton, H., Essig, D. A., & Kandarian, S. C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0866com · Cited by 281
Overview of the Muscle Cytoskeleton
Henderson, C. A., Gomez, C. G., Novak, S. M., Mi‐Mi, L., & Gregorio, C. C. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160033 · Cited by 278
Inflammation induced loss of skeletal muscle
Londhe, P., & Guttridge, D. C. (2015) · Bone · doi:10.1016/j.bone.2015.03.015 · Cited by 276
Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle
Stevenson, E. J., Giresi, P. G., Koncarevic, A., & Kandarian, S. C. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00033.x · Cited by 271 · cited 7×
“Interestingly, plakoglobin transcripts appear to be upregulated already 1 d after unloading [68], suggesting a compensatory response to early costamere-IR deregulation.”
BackgroundInfluentialWhite, J. P., Baynes, J. W., Welle, S. L., Kostek, M. C., Matesic, L. E., Sato, S., & Carson, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024650 · Cited by 260
Powers, S. K., Hudson, M. B., Nelson, W. B., Talbert, E. E., Min, K., Szeto, H. H., Kavazis, A. N., & Smuder, A. J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182190b62 · Cited by 255 · cited 2×
“In both cases, scavengers blunted the increase in oxidatively modified proteins and hampered the signaling required for atrophy progression, in the former case by reducing atrogene expression [88], and, in the latter one, by counteracting the loss of active nNOS from sarcolemma, an event which induces FoxO3 nuclear tr…”
BackgroundMethodDisruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy
Hunter, R. B., & Kandarian, S. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421696 · Cited by 250
The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
Mittal, A., Bhatnagar, S., Kumar, A., Lach-Trifilieff, E., Wauters, S., Li, H., Makonchuk, D. Y., Glass, D. J., & Kumar, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200909117 · Cited by 250 · cited 1×
“These cytokines, either released at distant sites, in the case of tumor-induced cachexia [50], or locally, from skeletal muscle and neighboring tissues, in denervation- and disuse-induced atrophy [51,52], activate the NF-κB pathway, fostering NF-κB activity and cytokine production and generating a vicious circle.”
BackgroundTumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
Zhang, G., Liu, Z., Ding, H., Zhou, Y., Doan, H. A., Sin, K. W. T., Zhu, Z. J., Flores, R., Wen, Y., Gong, X., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00726-x · Cited by 248
Hohenester, E., Tisi, D., Talts, J. F., & Timpl, R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80388-3 · Cited by 245
TNF‐related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle‐wasting cytokine
Dogra, C., Changoua, H., Wedhas, N., Qin, X., Wergedal, J. E., & Kumar, A. (2007) · The FASEB Journal · doi:10.1096/fj.06-7537com · Cited by 244 · cited 1×
“These cytokines, either released at distant sites, in the case of tumor-induced cachexia [50], or locally, from skeletal muscle and neighboring tissues, in denervation- and disuse-induced atrophy [51,52], activate the NF-κB pathway, fostering NF-κB activity and cytokine production and generating a vicious circle.”
BackgroundLateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats
Ramaswamy, K. S., Palmer, M. L., van der Meulen, J. H., Renoux, A., Kostrominova, T. Y., Michele, D. E., & Faulkner, J. A. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201921 · Cited by 236
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation
Winokur, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg327 · Cited by 232
How cells channel their stress: Interplay between Piezo1 and the cytoskeleton
Nourse, J. L., & Pathak, M. M. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.06.018 · Cited by 231
Benny Klimek, M. E., Aydogdu, T., Link, M. J., Pons, M., Koniaris, L. G., & Zimmers, T. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.123 · Cited by 229
Belkin, A. M., Zhidkova, N. I., Balzac, F., Altruda, F., Tomatis, D., Maier, A., Tarone, G., Koteliansky, V. E., & Burridge, K. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.211 · Cited by 229
Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle
Tidball, J. G., Lavergne, E., Lau, K. S., Spencer, M. J., Stull, J. T., & Wehling, M. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.1.c260 · Cited by 226
Cancer Cachexia: More Than Skeletal Muscle Wasting
Schmidt, S. F., Rohm, M., Herzig, S., & Berriel Diaz, M. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.10.001 · Cited by 220
Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle
Siu, P. M., & Alway, S. E. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.081083 · Cited by 216 · cited 1×
“Similarly, p53 protein content is markedly elevated in parallel with the upregulation of Bax, in rat gastrocnemius muscle after 14 d of denervation [67].”
BackgroundHyatt, H., Deminice, R., Yoshihara, T., & Powers, S. K. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.005 · Cited by 216 · cited 2×
“Indeed, dysfunctional mitochondria characterize long periods of muscle inactivity [93] and both dysregulation of mitochondria fusion and alteration in structure and function negatively affect muscle mass in several conditions [94].”
BackgroundSkeletal muscle gene expression in space-flown rats
Nikawa, T., Ishidoh, K., Hirasaka, K., Ishihara, I., Ikemoto, M., Kano, M., Kominami, E., Nonaka, I., Ogawa, T., Adams, G. R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0419fje · Cited by 212
Signaling Pathways That Control Muscle Mass
Vainshtein, A., & Sandri, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134759 · Cited by 212 · cited 4×
“Another relevant early player involved in FoxO3 activation by unloading is the loss of AMPK activity [19,20,31].”
BackgroundInfluentialGlobal analysis of gene expression patterns during disuse atrophy in rat skeletal muscle
Stevenson, E. J., Giresi, P. G., Koncarevic, A., et al. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.044701 · Cited by 212
Louis, H. A., Pino, J. D., Schmeichel, K. L., Pomiès, P., & Beckerle, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27484 · Cited by 211
Skeletal muscle gene expression profiles in 20–29 year old and 65–71 year old women
Welle, S., Brooks, A. I., Delehanty, J. M., Needler, N., Bhatt, K., Shah, B., & Thornton, C. A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.11.011 · Cited by 210
Redox control of skeletal muscle atrophy.
Powers, S. K., Morton, A. B., Ahn, B., & Smuder, A. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.021 · Cited by 207 · cited 2×
“Increased oxidative stress in the inactive muscle derives from the imbalance between the muscle anti-oxidant defense, reduced by the increase of protein catabolism, and the physiological oxidant production [85].”
BackgroundBohnert, K. R., McMillan, J. D., & Kumar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25852 · Cited by 207 · cited 4×
“This latter feature appears surprising, since ER-stress response activation is a relevant component of muscle atrophy development after denervation and in cancer cachexia [21,59], in addition to other muscle disorders [60].”
BackgroundInfluentialUnderstanding cachexia in the context of metastatic progression
Biswas, A. K., & Acharyya, S. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0251-4 · Cited by 197
Romanello, V., & Sandri, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03662-0 · Cited by 197
Mechanisms of stretch‐induced muscle damage in normal and dystrophic muscle: role of ionic changes
Allen, D. G., Whitehead, N. P., & Yeung, E. W. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.091694 · Cited by 196
Mitochondria, Muscle Health, and Exercise with Advancing Age
Carter, H. N., Chen, C. C. W., & Hood, D. A. (2015) · Physiology · doi:10.1152/physiol.00039.2014 · Cited by 191
Lateral Force Transmission Across Costameres in Skeletal Muscle
Bloch, R. J., & Gonzalez-Serratos, H. (2003) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200304000-00004 · Cited by 190
Nakao, R., Hirasaka, K., Goto, J., Ishidoh, K., Yamada, C., Ohno, A., Okumura, Y., Nonaka, I., Yasutomo, K., Baldwin, K. M., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01347-08 · Cited by 189
NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS
Suzuki, N., Motohashi, N., Uezumi, A., Fukada, S.-I., Yoshimura, T., Itoyama, Y., Aoki, M., Miyagoe-Suzuki, Y., & Takeda, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30654 · Cited by 188 · cited 10×
“The hypothetical accumulation of “uncoupled” active nNOS molecules in the sarcoplasm would be consistent with both the evidence of reduced NO production in unloaded muscles [107–109] and the requirement of an active sarcoplasmic nNOS to activate FoxO [27,30].”
BackgroundMethodResultInfluentialIntegrin signalling: The tug-of-war in heart hypertrophy
BRANCACCIO, M., HIRSCH, E., NOTTE, A., SELVETELLA, G., LEMBO, G., & TARONE, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.015 · Cited by 188
Self-citationTu, Y., Li, F., & Wu, C. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3367 · Cited by 187
Cachexia, Muscle Wasting, and Frailty in Cardiovascular Disease
Bielecka-Dabrowa, A., Ebner, N., dos Santos, M. R., Ishida, J., Hasenfuss, G., & von Haehling, S. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2011 · Cited by 181
IGF-1 is downregulated in experimental cancer cachexia
Costelli, P., Muscaritoli, M., Bossola, M., Penna, F., Reffo, P., Bonetto, A., Busquets, S., Bonelli, G., Lopez-Soriano, F. J., Doglietto, G. B., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00104.2006 · Cited by 175
Focal adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle
Flück, M., Carson, J. A., Gordon, S. E., Ziemiecki, A., & Booth, F. W. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.1.c152 · Cited by 175
Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program
Edwards, M. G., Anderson, R. M., Yuan, M., Kendziorski, C. M., Weindruch, R., & Prolla, T. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-80 · Cited by 174 · cited 2×
“This is confirmed by some evidence demonstrating that p53 is higher in older muscle tissue and regulates sarcopenia [64].”
BackgroundTRPC1 binds to caveolin-3 and is regulated by Src kinase – role in Duchenne muscular dystrophy
Gervásio, O. L., Whitehead, N. P., Yeung, E. W., Phillips, W. D., & Allen, D. G. (2008) · Journal of Cell Science · doi:10.1242/jcs.032003 · Cited by 169
Peng, H. B., Ali, A. A., Daggett, D. F., Rauvala, H., Hassell, J. R., & Smalheiser, N. R. (1998) · Cell Adhesion and Communication · doi:10.3109/15419069809005605 · Cited by 168
Atherton, P. J., Greenhaff, P. L., Phillips, S. M., Bodine, S. C., Adams, C. M., & Lang, C. H. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2016 · Cited by 168
The role of insulin resistance in the development of muscle wasting during cancer cachexia
Honors, M. A., & Kinzig, K. P. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0051-5 · Cited by 167
White, D. E., Coutu, P., Shi, Y.-F., Tardif, J.-C., Nattel, S., St. Arnaud, R., Dedhar, S., & Muller, W. J. (2006) · Genes & Development · doi:10.1101/gad.1458906 · Cited by 166
The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size
Watt, K. I., Turner, B. J., Hagg, A., Zhang, X., Davey, J. R., Qian, H., Beyer, C., Winbanks, C. E., Harvey, K. F., & Gregorevic, P. (2015) · Nature Communications · doi:10.1038/ncomms7048 · Cited by 164 · cited 11×
“YAP/TAZ positively regulate satellite cell/myoblast activation, and we tentatively speculate that dysfunctions in this pathway might play a relevant role in muscle atrophy development, especially in sarcopenia, where reduced recruitment of satellite cells appears to be mechanistically involved in loss of muscle mass […”
BackgroundInfluentialRanea, J. A. G., Mirey, G., Camonis, J., & Valencia, A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03321-5 · Cited by 160
Baldwin, K. M., Haddad, F., Pandorf, C. E., Roy, R. R., & Edgerton, V. R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00284 · Cited by 158 · cited 3×
“myosin gene down-regulation fiber type transition [2] multiple transcriptional changes phenotype change [68]”
BackgroundIntegrin signaling: linking mechanical stimulation to skeletal muscle hypertrophy
Boppart, M. D., & Mahmassani, Z. S. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00009.2019 · Cited by 157
Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism, and Physical Functioning
Lundholm, K., Körner, U., Gunnebo, L., Sixt-Ammilon, P., Fouladiun, M., Daneryd, P., & Bosaeus, I. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2720 · Cited by 156
Pišot, R., Marusic, U., Biolo, G., Mazzucco, S., Lazzer, S., Grassi, B., Reggiani, C., Toniolo, L., di Prampero, P. E., Passaro, A., et al. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00858.2015 · Cited by 150 · cited 1×
“Muscle mass loss is fast (about 18% in a month in a young human, the same amount in a week in an old one) [3], mostly due to myofiber atrophy, which involves all the fiber type populations, and is accompanied by a slow-to-fast fiber type transition, as recently reviewed by Vikne et al.”
BackgroundBusquets, S., Toledo, M., Orpí, M., Massa, D., Porta, M. M., Capdevila, E., Padilla, N., Frailis, V., López-Soriano, F. J., Han, H. Q., et al. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0049-z · Cited by 145
Focal adhesion kinase and its role in skeletal muscle
Graham, Z., Gallagher, P. M., & Cardozo, C. P. (2015) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-015-9415-3 · Cited by 144
Gordon, S. E., Flück, M., & Booth, F. W. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.3.1174 · Cited by 142
Zhang, M., Kadota, Y., Prodromou, C., Shirasu, K., & Pearl, L. H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.010 · Cited by 141
Fox, D. K., Ebert, S. M., Bongers, K. S., Dyle, M. C., Bullard, S. A., Dierdorff, J. M., Kunkel, S. D., & Adams, C. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2014 · Cited by 138 · cited 5×
“sarcoplasm/nucleus increased p53 protein levels MuRF-1 and p21 upregulation [57]”
BackgroundInfluentialMuscle cachexia is regulated by a p53–PW1/Peg3-dependent pathway
Schwarzkopf, M., Coletti, D., Sassoon, D. A., & Marazzi, G. (2006) · Genes & Development · doi:10.1101/gad.412606 · Cited by 138 · cited 6×
“Consistently, p53-null mice are prone to cancer development but resistant to cancer-induced muscle atrophy [74].”
BackgroundInfluentialHuman Sgt1 Binds HSP90 through the CHORD-Sgt1 Domain and Not the Tetratricopeptide Repeat Domain*
Lee, Y.-T., Jacob, J., Michowski, W., Nowotny, M., Kuźnicki, J., & Chazin, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400215200 · Cited by 136
Murphy, K. T., Koopman, R., Naim, T., Léger, B., Trieu, J., Ibebunjo, C., & Lynch, G. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-159608 · Cited by 134
Role for IκBα, but not c-Rel, in skeletal muscle atrophy
Judge, A. R., Koncarevic, A., Hunter, R. B., Liou, H., Jackman, R. W., & Kandarian, S. C. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00293.2006 · Cited by 134
Ros‐mediated activation of NF‐κB and Foxo during muscle disuse
Dodd, S. L., Gagnon, B. J., Senf, S. M., Hain, B. A., & Judge, A. R. (2010) · Muscle & Nerve · doi:10.1002/mus.21526 · Cited by 131
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies
Gawlik, K. I., & Durbeej, M. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-9 · Cited by 131
Ballak, S. B., Degens, H., HAAN, A. D., & Jaspers, R. T. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.005 · Cited by 130 · cited 1×
“Sarcopenia implies a gradual loss of muscle strength, which starts in humans after the age of 60, often preceding the decrease in myofiber number and size, and preferentially involving the fast fiber population [8].”
BackgroundHDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy
Beharry, A. W., Sandesara, P. B., Roberts, B. M., Ferreira, L. F., Senf, S. M., & Judge, A. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.136390 · Cited by 128 · cited 4×
“Loss of active Akt and deacetylation are recognized activators of FoxO3 nuclear translocation [32], the former resulting from blunted IR signaling and the latter from class I HDAC non-histone activity [33].”
BackgroundInfluentialLü, H., Fedak, P. W. M., Dai, X., Du, C., Zhou, Y., Henkelman, R. M., Mongroo, P. S., Lau, A. N., Yamabi, H., Hinek, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.642330 · Cited by 128
MUSCLE DISUSE AS A PIVOTAL PROBLEM IN SARCOPENIA-RELATED MUSCLE LOSS AND DYSFUNCTION
Bell, K. E., von Allmen, M., Devries, M. C., & Phillips, S. M. (2016) · The Journal of Frailty & Aging · doi:10.14283/jfa.2016.78 · Cited by 127 · cited 1×
“Age-related muscle wasting (sarcopenia) leads not only to a decline in performance and fitness of elderly people, but also to an increased risk of falls and progressive loss of functional independence in daily activities [6,7].”
BackgroundThe muscle regulatory and structural protein MLP is a cytoskeletal binding partner of βI-spectrin
Flick, M. J., & Konieczny, S. F. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.9.1553 · Cited by 126
MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity
Moretti, I., Ciciliot, S., Dyar, K. A., Abraham, R., Murgia, M., Agatea, L., Akimoto, T., Bicciato, S., Forcato, M., Pierre, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms12397 · Cited by 122
mTORC1 and PKB/Akt control the muscle response to denervation by regulating autophagy and HDAC4
Castets, P., Rion, N., Théodore, M., Falcetta, D., Lin, S., Reischl, M., Wild, F., Guérard, L., Eickhorst, C., Brockhoff, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11227-4 · Cited by 122
Postel, R., Vakeel, P., Topczewski, J., Knöll, R., & Bakkers, J. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.03.024 · Cited by 121
Maintenance of muscle mass and load‐induced growth in Muscle RING Finger 1 null mice with age
Hwee, D. T., Baehr, L. M., Philp, A., Baar, K., & Bodine, S. C. (2014) · Aging Cell · doi:10.1111/acel.12150 · Cited by 121 · cited 2×
“Furthermore, FoxO apparently does not play a role in sarcopenia development [25], whereas MuRF1 is involved, since its deletion resulted in the maintenance of muscle mass with age [26].”
BackgroundVandebrouck, A., Sabourin, J., Rivet, J., Balghi, H., Sebille, S., Kitzis, A., Raymond, G., Cognard, C., Bourmeyster, N., & Constantin, B. (2007) · The FASEB Journal · doi:10.1096/fj.06-6683com · Cited by 119
Melusin Is a New Muscle-specific Interactor for β1Integrin Cytoplasmic Domain
Brancaccio, M., Guazzone, S., Menini, N., Sibona, E., Hirsch, E., Andrea, M. D., Rocchi, M., Altruda, F., Tarone, G., & Silengo, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29282 · Cited by 116
Self-citationPosttranslational modifications control FoxO3 activity during denervation
Bertaggia, E., Coletto, L., & Sandri, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00142.2011 · Cited by 114 · cited 8×
“Loss of active Akt and deacetylation are recognized activators of FoxO3 nuclear translocation [32], the former resulting from blunted IR signaling and the latter from class I HDAC non-histone activity [33].”
BackgroundInfluentialInducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia
Hall, D. T., Ma, J. F., Marco, S. D., & Gallouzi, I. (2011) · Aging · doi:10.18632/aging.100358 · Cited by 113
Wang, H.-V., Chang, L.-W., Brixius, K., Wickström, S. A., Montanez, E., Thievessen, I., Schwander, M., Müller, U., Bloch, W., Mayer, U., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200707175 · Cited by 112
Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null mice
Li, D., Yue, Y., Lai, Y., Hakim, C. H., & Duan, D. (2010) · The Journal of Pathology · doi:10.1002/path.2799 · Cited by 110
A Common MLP (Muscle LIM Protein) Variant Is Associated With Cardiomyopathy
Knöll, R., Sawa Kostin, D., Klede, S., Savvatis, K., Klinge, L., Stehle, I., Gunkel, S., Kötter, S., Babicz, K., Sohns, M., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.206243 · Cited by 110
The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy
Gammeren, D. V., Damrauer, J. S., Jackman, R. W., & Kandarian, S. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-114249 · Cited by 109
Pearson, T., Kabayo, T., Ng, R., Chamberlain, J., McArdle, A., & Jackson, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096378 · Cited by 107 · cited 2×
“Indeed, unbiased direct demonstration of increased oxidant accumulation requires specific approaches/probes and use of intact muscle or isolated myofibers [83,92].”
BackgroundLeaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation
Matecki, S., Dridi, H., Jung, B., Saint, N., Reiken, S. R., Scheuermann, V., Mrozek, S., Santulli, G., Umanskaya, A., Petrof, B. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609707113 · Cited by 107 · cited 1×
“Additional possible mechanisms leading to increased mitochondrial ROS production after prolonged muscle unloading/inactivity were identified by changes in cardiolipin amount and composition [97], or increased mitochondrial Ca2+ secondary to ryanodine receptor 1 (RYR1) leakage [98].”
BackgroundShen, Y., Zhang, R., Xu, L., Wan, Q., Zhu, J., Gu, J., Huang, Z., Ma, W., Shen, M., Ding, F., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01298 · Cited by 107 · cited 20×
“However, the upregulation of chaperones and enzymes involved in the anti-oxidant defense occurs before muscle atrophy development, supporting the hypothesis that the increase in oxidant production anticipates the increase in protein catabolism [86,87].”
BackgroundInfluentialAcetis, M. D., Notte, A., Accornero, F., Selvetella, G., Brancaccio, M., Vecchione, C., Sbroggió, M., Collino, F., Pacchioni, B., Lanfranchi, G., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000168028.36081.e0 · Cited by 105
Self-citationMcMahon, C. D., Popović, L., Oldham, J. M., Jeanplong, F., Smith, H. K., Kambadur, R., Sharma, M., Maxwell, L., & Bass, J. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00275.2002 · Cited by 104 · cited 1×
“However, myostatin contribution appears dispensable in the development of muscle unloading atrophy [54].”
BackgroundPhosphoproteomic analysis of aged skeletal muscle
Gannon, J. M., Staunton, L., O’Connell, K. M., Doran, P., & Ohlendieck, K. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.22.1.33 · Cited by 104
Trim32 reduces PI3K–Akt–FoxO signaling in muscle atrophy by promoting plakoglobin–PI3K dissociation
Cohen, S., Lee, D., Zhai, B., Gygi, S. P., & Goldberg, A. L. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201304167 · Cited by 103
Muscle LIM Protein: Master regulator of cardiac and skeletal muscle functions
Vafiadaki, E., Arvanitis, D. A., & Sanoudou, D. (2015) · Gene · doi:10.1016/j.gene.2015.04.077 · Cited by 102
Cholesterol and lipid microdomains stabilize the postsynapse at the neuromuscular junction
Willmann, R., Pun, S., Stallmach, L., Sadasivam, G., Santos, A. F., Caroni, P., & Fuhrer, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601288 · Cited by 102
Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94
Ansa-Addo, E. A., Thaxton, J. E., Hong, F., Wu, B. X., Zhang, Y., Fugle, C. W., Metelli, A., Riesenberg, B., Williams, K. M., Gewirth, D. T., et al. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160413141613 · Cited by 101
Tissue-specific Role of the Na,K-ATPase α2 Isozyme in Skeletal Muscle
Radzyukevich, T. L., Neumann, J. C., Rindler, T. N., Oshiro, N., Goldhamer, D. J., Lingrel, J. B., & Heiny, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.424663 · Cited by 100
Shen, Y., Zhang, Q., Huang, Z., Zhu, J., Qiu, J., Ma, W., Yang, X., Ding, F., & Sun, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00988 · Cited by 100
HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
Luo, L., Martin, S. C., Parkington, J. D., Cadena, S. M., Zhu, J., Ibebunjo, C., Summermatter, S., Londraville, N., Patora‐Komisarska, K., Widler, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.023 · Cited by 97
Spangenburg, E. E., & McBride, T. A. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00619.2005 · Cited by 96
Effects of aging, exercise, and disease on force transfer in skeletal muscle
Hughes, D. C., Wallace, M. A., & Baar, K. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00095.2015 · Cited by 95 · cited 2×
“Changes at this level or at costamere anchoring to myofibrils may lead to impaired force transfer and cause the loss in muscle strength occurring in the aged muscle, especially in the presence of a light reduction in muscle mass [15].”
BackgroundSamengo, G., Avik, A., Fedor, B., Whittaker, D., Myung, K. H., Wehling‐Henricks, M., & Tidball, J. G. (2012) · Aging Cell · doi:10.1111/acel.12003 · Cited by 95
Gano, J., & Simon, J. A. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900261-mcp200 · Cited by 95
Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice
Winbanks, C. E., Murphy, K. T., Bernardo, B. C., Qian, H., Liu, Y., Sepulveda, P. V., Beyer, C., Hagg, A., Thomson, R. E., Chen, J. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4976 · Cited by 95
Brocca, L., Toniolo, L., Reggiani, C., Bottinelli, R., Sandri, M., & Pellegrino, M. A. (2017) · The Journal of Physiology · doi:10.1113/jp273097 · Cited by 93 · cited 7×
“However, AICAR did not blunt MAFbx/Atrogin-1 and MuRF-1 upregulation [31], suggesting that other pathways than phosphorylated p70S6K are involved.”
BackgroundInfluentialMacrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia
Shukla, S. K., Markov, S. D., Attri, K. S., Vernucci, E., King, R. J., Dasgupta, A., Grandgenett, P. M., Hollingsworth, M. A., Singh, P. K., Yu, F., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.017 · Cited by 89
Libera, L. D., Ravara, B., Gobbo, V., Tarricone, E., Vitadello, M., Biolo, G., Vescovo, G., & Gorza, L. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00280.2009 · Cited by 87 · cited 1×
“However, the upregulation of chaperones and enzymes involved in the anti-oxidant defense occurs before muscle atrophy development, supporting the hypothesis that the increase in oxidant production anticipates the increase in protein catabolism [86,87].”
BackgroundSelf-citationGSK3-β promotes calpain-1–mediated desmin filament depolymerization and myofibril loss in atrophy
Aweida, D., Rudesky, I., Volodin, A., Shimko, E., & Cohen, S. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201802018 · Cited by 80
The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function
Watt, K. I., Goodman, C. A., Hornberger, T. A., & Gregorevic, P. (2018) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000142 · Cited by 78 · cited 5×
“Sustained increase in YAP transcription, phosphorylation at Ser112, and total protein occurred along 14 d post-denervation, concomitantly with the protein localization in myonuclei [22].”
BackgroundInfluentialAge-dependent skeletal muscle transcriptome response to bed rest-induced atrophy
Mahmassani, Z. S., Reidy, P. T., McKenzie, A. I., Stubben, C., Howard, M. T., & Drummond, M. J. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00811.2018 · Cited by 78
Skeletal muscle disuse induces fibre type-dependent enhancement of Na+ channel expression
Desaphy, J., Pierno, S., Léoty, C., George, A. L., Luca, A. D., & Camerino, D. C. (2001) · Brain · doi:10.1093/brain/124.6.1100 · Cited by 75
Calura, E., Cagnin, S., Raffaello, A., Laveder, P., Lanfranchi, G., & Romualdi, C. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-630 · Cited by 74 · cited 1×
“Although atrogenes are involved in muscle protein catabolism, they represent a minor shared component of the broad transcriptome change accompanying skeletal muscle atrophy development in each of the described conditions [18].”
BackgroundHarris, M. B., Mitchell, B. M., Sood, S. G., Webb, R. C., & Venema, R. C. (2008) · European Journal of Applied Physiology · doi:10.1007/s00421-008-0833-4 · Cited by 74
MST1, a key player, in enhancing fast skeletal muscle atrophy
Wei, B. K., Dui, W., Liu, D., Yan, X., Yuan, Z., & Ji, G. (2013) · BMC Biology · doi:10.1186/1741-7007-11-12 · Cited by 72 · cited 1×
“Loss of muscle innervation activates the Hippo pathway and the inhibition of MST1 is sufficient to prevent atrophy in denervated, fast-twitch muscles [79].”
BackgroundChanges in Redox Signaling in the Skeletal Muscle with Aging
Szentesi, P., Csernoch, L., Dux, L., & Keller-Pintér, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4617801 · Cited by 71
Neuronal involvement in muscular atrophy
Cisterna, B. A., Cardozo, C. P., & Sáez, J. C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00405 · Cited by 70
Hughes, D. C., Marcotte, G. R., Marshall, A. G., West, D. W. D., Baehr, L. M., Wallace, M. A., Saleh, P. M., Bodine, S. C., & Baar, K. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw109 · Cited by 70
Henríquez‐Olguín, C., Meneses‐Valdés, R., & Jensen, T. E. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101473 · Cited by 70 · cited 3×
“NADPH-oxidases appear the major source of cytosolic ROS during acute exercise bouts and are involved in exercise-induced changes, such as the translocation of the glucose transporter 4 (GLUT-4) and the activation of pro-trophic pathways [84].”
BackgroundFurlow, J. D., Watson, M. L., Waddell, D. S., Neff, E. S., Baehr, L. M., Ross, A. P., & Bodine, S. C. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00022.2013 · Cited by 69
Costamere proteins and their involvement in myopathic processes
Jaka, O., Casas-Fraile, L., de Munaín, A. L., & Sáenz, A. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.9 · Cited by 69
Membrane lipid rafts are disturbed in the response of rat skeletal muscle to short-term disuse
Petrov, A. M., Васильевна, К. В., Matchkov, V. V., Vasiliev, A. N., Zefirov, A. L., Chibalin, A., Heiny, J. A., & Krivoi, I. I. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00365.2016 · Cited by 69
Vikne, H., Strøm, V., Pripp, A. H., & Gjøvaag, T. F. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13675 · Cited by 69
Evidences of apoptosis during the early phases of soleus muscle atrophy in hindlimb suspended mice
Ferreira, R. M., Neuparth, M. J., Vitorino, R. M. P., Appell, H.-J., Amado, F. M. L., & Duarte, J. (2008) · Physiological Research · doi:10.33549/physiolres.931272 · Cited by 68
BAR‐SHAI, M., CARMELI, E., & REZNICK, A. Z. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1356.034 · Cited by 67
Beltran Valls, M. R., Wilkinson, D. J., Narici, M. V., Smith, K., Phillips, B. E., Caporossi, D., & Atherton, P. J. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu007 · Cited by 66
Marcucci, L., & Reggiani, C. (2020) · European Journal of Translational Myology · doi:10.4081/ejtm.2020.8982 · Cited by 66
Durieux, A., D’Antona, G., Desplanches, D., Freyssenet, D. G., Klossner, S., Bottinelli, R., & Flück, M. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.171355 · Cited by 65
Vitadello, M., Doria, A., Tarricone, E., Ghirardello, A., & Gorza, L. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2963 · Cited by 65 · cited 1×
“Indeed, the ER-stress response plays a relevant role in the regulation of the muscle mass, being involved in its maintenance in cancer cachexia and during muscle maturation [21,61].”
BackgroundSelf-citationUchida, T., Sakashita, Y., Kitahata, K., Yamashita, Y., Tomida, C., Kimori, Y., Komatsu, A., Hirasaka, K., Ohno, A., Nakao, R., et al. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00184.2017 · Cited by 64
Redox modulation of muscle mass and function
Gómez‐Cabrera, M. C., Arc‐Chagnaud, C., Salvador‐Pascual, A., Brioche, T., Chopard, A., González, G. O., & Viña, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101531 · Cited by 63 · cited 1×
“Skeletal muscle atrophy, secondary to unloading, denervation, fasting or FoxO3 overexpression, relieves after counteracting the downregulation of PGC-1α, the master regulator for mitochondrial biogenesis [95,96].”
BackgroundNichols, B. M., Takeda, S., & Yokota, T. (2015) · Brain Sciences · doi:10.3390/brainsci5030275 · Cited by 62
Reed, S. A., Senf, S. M., Cornwell, E. W., Kandarian, S. C., & Judge, S. M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.059 · Cited by 62 · cited 1×
“Both the canonical and the alternative NF-κB pathways play a role in atrophy induced by unloading [38,43–45] and the inhibition of IKKα or IKKβ activity, through the overexpression of dominant negative enzymes, robustly inhibits atrophy induced by 7 d of unloading in rats [45,46].”
BackgroundId2 and p53 participate in apoptosis during unloading-induced muscle atrophy
Siu, P. M., & Alway, S. E. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00495.2004 · Cited by 62
Yang, Q., Huo, Y., Han, Y., Lili, W., Li, J., Huang, J., Jin, L., Peng-Guo, C., Gan, R., & Guo, C. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0324 · Cited by 62
The Na/K-ATPase Signaling: From Specific Ligands to General Reactive Oxygen Species
Pratt, R. D., Brickman, C., Cottrill, C. L., Shapiro, J. I., & Liu, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092600 · Cited by 62
Endoplasmic Reticulum Chaperone Glucose-Regulated Protein 94 Is Essential for Proinsulin Handling
Ghiasi, S. M., Dahlby, T., Andersen, C. H., Haataja, L., Petersen, S., Omar‐Hmeadi, M., Yang, M., Pihl, C., Bresson, S. E., Khilji, M. S., et al. (2019) · Diabetes · doi:10.2337/db18-0671 · Cited by 62 · cited 1×
“Grp94/gp96 not only has muscle-required growth factors (GF), like Insulin-like GF-I and -II, and pro-insulin, as exclusive clients for folding [62], but also interacts with several non-client proteins, among which nNOS (see Section 2.”
BackgroundRole of the integrin-linked kinase/PINCH1/alpha-parvin complex in cardiac myocyte hypertrophy
Chen, H., Huang, X. N., Yan, W., Chen, K., Guo, L., Tummalapali, L., Dedhar, S., St‐Arnaud, R., Wu, C., & Sepulveda, J. L. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700345 · Cited by 61
Sbroggió, M., Bertero, A., Velasco, S., Fusella, F., Blasio, E. D., Bahou, W. F., Silengo, L., Turco, E., Brancaccio, M., & Tarone, G. (2011) · Journal of Cell Science · doi:10.1242/jcs.091140 · Cited by 61
Self-citationde Oliveira, A. G., & Gomes‐Marcondes, M. C. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2424-9 · Cited by 61
IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
Schmidt, K., von Haehling, S., Doehner, W., Palus, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0029-3 · Cited by 60
Muscle LIM protein plays both structural and functional roles in skeletal muscle
Barash, I. A., Mathew, L., Lahey, M., Greaser, M. L., & Lieber, R. L. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00117.2005 · Cited by 59
Mutlak, Y. E., Aweida, D., Volodin, A., Ayalon, B., Dahan, N., Parnis, A., & Cohen, S. (2020) · Nature Communications · doi:10.1038/s41467-020-14895-9 · Cited by 59
Ayalon, G., Hostettler, J., Hoffman, J. A., Kizhatil, K., Davis, J. Q., & Bennett, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187831 · Cited by 58
p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin
Ehrnhoefer, D. E., Skotte, N. H., Ladha, S., Nguyen, Y. T. N., Qiu, X., Deng, Y., Huynh, K. T., Engemann, S., Nielsen, S. M., Bečanović, K., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt458 · Cited by 56
Leiter, J., Upadhaya, R., & Anderson, J. E. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00305.2011 · Cited by 56
The Autophagy Regulatory Molecule CSRP3 Interacts with LC3 and Protects Against Muscular Dystrophy
Cui, C., Han, S., Tang, S., He, H., Shen, X., Zhao, J., Chen, Y., Wei, Y., Wang, Y., Zhu, Q. C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030749 · Cited by 56
Pollock, N., Staunton, C. A., Vasilaki, A., McArdle, A., & Jackson, M. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.017 · Cited by 55
Skeletal muscle repair in a mouse model of nemaline myopathy
Sanoudou, D., Corbett, M. A., Han, M., Ghoddusi, M., Nguyen, M.-A. T., Vlahovich, N., Hardeman, E. C., & Beggs, A. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl186 · Cited by 54
McKenna, C. F., & Fry, C. S. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000409 · Cited by 54 · cited 3×
“On the other hand, myostatin negatively regulates satellite cell proliferation and commitment to differentiation, reducing the recruitment of satellite cells [81].”
BackgroundGheyara, A. L., Vallejo‐Illarramendi, A., Zang, K., Mei, L., St.-Arnaud, R., Dedhar, S., & Reichardt, L. F. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070555 · Cited by 53
Lang, F., Khaghani-Razi-Abad, S., Türk, C., Wiederstein, J. L., Hölper, S., Piller, T., Nogara, L., Blaauw, B., Günther, S., Müller, S., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00093 · Cited by 53 · cited 1×
“apparently depends on its fiber type composition, since each fiber type shows marked difference in proteome remodeling [5].”
BackgroundUnsöld, B. W., Kaul, A., Sbroggió, M., Schubert, C., Regitz‐Zagrosek, V., Brancaccio, M., Damilano, F., Hirsch, E., van Bilsen, M., Munts, C., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt235 · Cited by 52
Self-citationnNOS regulation of skeletal muscle fatigue and exercise performance
Percival, J. M. (2011) · Biophysical Reviews · doi:10.1007/s12551-011-0060-9 · Cited by 52
Research works printed but not linked: 1
- Choi, S. (2018). Grp94 (HSP90B1). Encyclopedia of Signaling Molecules, Springer International Publishing.
Cited by
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
BackgroundDowling, P., Gargan, S., Murphy, S., Zweyer, M., Sabir, H., Swandulla, D., & Ohlendieck, K. (2021) · Proteomes · doi:10.3390/proteomes9010009 · Cited by 56
“Dystrophin-associated nitric oxide synthase, the enzyme responsible for the production of the key signaling molecule nitric oxide, was shown to play a regulatory role in costameres [132] and is involved in muscle fatigue, muscular atrophy and certain forms of muscular dystrophy [36,133,134].”
BackgroundGenetic Insights into Primary Restrictive Cardiomyopathy
Brodehl, A., & Gerull, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082094 · Cited by 47
Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy
Chen, R., Yuan, W., Zheng, Y., Zhu, X., Jin, B., Yang, T., Yan, Y., Xu, W., Chen, H., Gao, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01508-4 · Cited by 36
Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction
Leser, J. M., Harriot, A. D., Buck, H., Ward, C. W., & Stains, J. P. (2021) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.782848 · Cited by 33
Metadata
- Authors
- Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M.
- Affiliations
- University of Padua (IT)
- University of Turin (IT)
- Corresponding author
- Gorza, Luisa
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-01-03
- Volume
- 10
- Issue
- 1
- Pages
- 61
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7823551
- OpenAlex
- W3120265875
- Cited by
- 31
- References
- 299
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 7
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Università degli Studi di Padova (GORZ_FINA_P13_01)
- Università degli Studi di Torino (Ricerca Locale 2019)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- muscle atrophy, costameres, neuronal nitric oxide synthase, atrogenes, mechanical signaling, muscle mass regulation, insulin signaling, insulin-like growth factor, sarcolemma, extracellular matrix, transcription factors
- MeSH terms
- Animals, Humans, Models, Biological, Muscular Atrophy, Signal Transduction, Oxidative Stress, Mechanotransduction, Cellular, Costameres
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.